Dianthus Therapeutics, Inc. /DE/ financial data

Symbol
DNTH on Nasdaq
Industry
Pharmaceutical Preparations
Location
300 Technology Square, 8 Th Floor, Cambridge, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Magenta Therapeutics, Inc. (to 9/8/2023)
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.32 K % +103%
Debt-to-equity 5.84 %
Return On Equity -30.5 % -139%
Return On Assets -24.1 % +0.62%
Operating Margin -463 % +47.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 29.3 M shares -51.6%
Common Stock, Shares, Outstanding 29.3 M shares -51.6%
Entity Public Float 32.1 M USD +57015886%
Common Stock, Value, Issued 29 K USD -52.5%
Weighted Average Number of Shares Outstanding, Basic 25.7 M shares +2834%
Weighted Average Number of Shares Outstanding, Diluted 25.7 M shares +2834%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 924 K USD -21.2%
Research and Development Expense 40.1 M USD +115%
General and Administrative Expense 21.5 M USD +1115%
Operating Income (Loss) -58.3 M USD -330%
Nonoperating Income (Expense) 4.1 M USD +590%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -50.2 M USD -63.6%
Earnings Per Share, Basic -0.89 USD/shares +97.8%
Earnings Per Share, Diluted -0.89 USD/shares +97.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 330 M USD +1320%
Marketable Securities, Current 54.4 M USD +20.2%
Accounts Receivable, after Allowance for Credit Loss, Current 435 K USD
Other Assets, Current 53 K USD +430%
Assets, Current 381 M USD +357%
Property, Plant and Equipment, Net 195 K USD
Operating Lease, Right-of-Use Asset 530 K USD
Assets 382 M USD +358%
Accounts Payable, Current 2.61 M USD +142%
Employee-related Liabilities, Current 1.44 M USD -11%
Accrued Liabilities, Current 5.85 M USD
Liabilities, Current 8.96 M USD +49.8%
Operating Lease, Liability, Noncurrent 97 K USD
Liabilities 9.78 M USD +63.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -27 K USD -68.8%
Retained Earnings (Accumulated Deficit) -103 M USD +76.1%
Stockholders' Equity Attributable to Parent 373 M USD
Liabilities and Equity 382 M USD +358%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.9 M USD -45.3%
Net Cash Provided by (Used in) Financing Activities 218 M USD
Net Cash Provided by (Used in) Investing Activities -5.51 M USD -130%
Common Stock, Shares Authorized 150 M shares 0%
Common Stock, Shares, Issued 29.3 M shares -51.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 197 M USD +2416%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 330 M USD +1317%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 123 M USD +967%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 137 M USD +1063%
Operating Lease, Liability 497 K USD
Depreciation 22 K USD +57.1%
Payments to Acquire Property, Plant, and Equipment 245 K USD +807%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -50.2 M USD -310%
Lessee, Operating Lease, Liability, to be Paid 536 K USD
Property, Plant and Equipment, Gross 314 K USD
Operating Lease, Liability, Current 400 K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 222 K USD -39.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 222 K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 39 K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 188 K USD
Deferred Tax Assets, Operating Loss Carryforwards 73.6 M USD +1267%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.06 M USD
Operating Lease, Payments 19.8 M USD -100%
Preferred Stock, Shares Outstanding 0 shares
Operating Leases, Future Minimum Payments, Due in Two Years 7.31 M USD +14.7%
Depreciation, Depletion and Amortization 421 K USD -17.6%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 6.94 M USD
Deferred Tax Assets, Net of Valuation Allowance 13.3 M USD +6690%
Share-based Payment Arrangement, Expense 4.4 M USD +2915%
Operating Leases, Future Minimum Payments, Due in Three Years 7.68 M USD +14%
Operating Leases, Future Minimum Payments Due 44.9 M USD -9.73%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%